Merck
CN
  • Systematic alteration of in vitro metabolic environments reveals empirical growth relationships in cancer cell phenotypes.

Systematic alteration of in vitro metabolic environments reveals empirical growth relationships in cancer cell phenotypes.

Cell reports (2021-01-21)
Karl Kochanowski, Timur Sander, Hannes Link, Jeremy Chang, Steven J Altschuler, Lani F Wu
摘要

Cancer cells, like microbes, live in complex metabolic environments. Recent evidence suggests that microbial behavior across metabolic environments is well described by simple empirical growth relationships, or growth laws. Do such empirical growth relationships also exist in cancer cells? To test this question, we develop a high-throughput approach to extract quantitative measurements of cancer cell behaviors in systematically altered metabolic environments. Using this approach, we examine relationships between growth and three frequently studied cancer phenotypes: drug-treatment survival, cell migration, and lactate overflow. Drug-treatment survival follows simple linear growth relationships, which differ quantitatively between chemotherapeutics and EGFR inhibition. Cell migration follows a weak grow-and-go growth relationship, with substantial deviation in some environments. Finally, lactate overflow is mostly decoupled from growth rate and is instead determined by the cells' ability to maintain high sugar uptake rates. Altogether, this work provides a quantitative approach for formulating empirical growth laws of cancer.

材料
货号
品牌
产品描述

Sigma-Aldrich
羰基氰化物 4-(三氟甲氧基)苯腙, ≥98% (TLC), powder
Sigma-Aldrich
鱼藤酮, ≥95%
Sigma-Aldrich
依托泊苷, synthetic, 95.0-105.0%, powder
Sigma-Aldrich
草氨酸钠, ≥98%
Sigma-Aldrich
麦芽糖 溶液, BioReagent, for molecular biology, ~20% in H2O
Sigma-Aldrich
溴丙酮酸, ≥98.0%